High frequency of cryptic chromosomal rearrangements involving the LMO2 gene in T-cell acute lymphoblastic leukemia

Haematologica

Volumn 100, Issue 6, 2015, Pages e233-e236

  Wu, Lili ^a   Xu, Yang ^a   Wang, Qian ^a   Ruan, Changgeng ^a   Drexler, Hans G ^b   Wu, Depei ^a   Macleod, Roderick A F ^b   Chen, Suning ^a,c  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

Expression; LMO2; Rearrangement; T cell acute lymphoblastic leukemia

Indexed keywords

FBXW7 PROTEIN; HEMOGLOBIN; INTERLEUKIN 7 RECEPTOR; LACTATE DEHYDROGENASE; MESSENGER RNA; NOTCH1 RECEPTOR; PHD FINGER PROTEIN 6; PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG; WT1 PROTEIN; LIM PROTEIN; LMO2 PROTEIN, HUMAN; ONCOPROTEIN; RNA SPLICING; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; CHILD; CHROMOSOME ABERRATION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; HEPATOMEGALY; HUMAN; KARYOTYPE; LETTER; LMO2 GENE; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLENOMEGALY; T CELL LEUKEMIA; AMINO ACID SEQUENCE; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RNA SPLICING; VERY ELDERLY; YOUNG ADULT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; CHILD; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; LIM DOMAIN PROTEINS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS; RNA SPLICE SITES; YOUNG ADULT;

EID: 84930517828     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2014.120089     Document Type: Letter

References (14)

1. Dik WA, Nadel B, Przybylski GK, et al. Different chromosomal breakpoints impact the level of LMO2 expression in T-ALL. Blood. 2007;110(1):388-392.
2. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X 1. Science. 2003;302(5644):415-419.
3. McCormack MP, Rabbitts TH. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2004;350(9):913-922.
4. Howe SJ, Mansour MR, Schwarzwaelder K, et al. Insertional mutagenes combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest. 2008;118(9):3143-3150.
5. Van Vlierberghe P, van Grotel M, Beverloo HB, et al. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood. 2006;108(10):3520-3529.
6. Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1(1):75-87.
7. Chen S, Nagel S, Schneider B, et al. Novel non-TCR chromosome translocations t(3;11)(q25;p13) and t(X;11)(q25;p13) activating LMO2 by juxtaposition with MBNL1 and STAG 2. Leukemia. 2011;25(10):1632-1635.
8. Shaffer LG, Slovak ML, Campbell LJ, eds. ISCN 2009: an international system for human cytogenetic nomenclature. Basel: Karger; 2009.
9. Cubedo E, Gentles AJ, Huang C, et al. Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma. Blood. 2012;119(23):5478-91.
10. Fitzgerald TJ, Neale GA, Raimondi SC, Goorha RM. Rhom-2 expression does not always correlate with abnormalities on chromosome 11 at band p13 in T-cell acute lymphoblastic leukemia. Blood. 1992;80(12):3189-3197.
11. MacLeod RA, Nagel S, Kaufmann M, Janssen JW, Drexler HG. Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2). Genes Chromosomes Cancer. 2003; 37(1):84-91.
12. Nagel S, Kaufmann M, Drexler HG, MacLeod RA. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). Cancer Res. 2003;63(17):5329-5334.
13. Nagel S, Scherr M, Kel A, et al. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA 1. Cancer Res. 2007;67(4):1461-1471.
14. Li L, Zhang JA, Dose M, et al. A far downstream enhancer for murine Bcl11b controls its T-cell specific expression. Blood. 2013;122(6):902-911.